⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GSK News
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
Catalyst Monitor Report: Q1 2026 Outlook: Regulatory Approvals and Late-Stage Trials Signal Strong Pipeline Momentum Across Key Therapeutic Areas
globenewswire.com
GSK
RGNX
OMER
XENE
NMRA
Alteogen Announces Exclusive License Agreement with Tesaro, a Subsidiary of GSK, for the Development of a Subcutaneous Formulation of Dostarlimab Enabled by Hybrozyme™ Technology
prnewswire.com
GSK
Global Antibody Drug Conjugates Market to Surge from USD 12.26 Billion in 2024 to USD 32.11 Billion by 2033
globenewswire.com
GSK
Marquis Who's Who Honors David Grote for Leadership in Pharmaceutical Quality Assurance
accessnewswire.com
AMGN
TEVA
GSK
7MM Chronic Hepatitis B Therapeutics Market Drug Forecast and Market Analysis Report 2024-2034: Addressing Unmet Needs, Late-Stage Pipelines and Functional Cure Therapies Drive Growth
globenewswire.com
GSK
GILD
ALGS
How to Improve Accuracy and Attention to Detail in Pharma Training Course (Apr 23, 2026) - ResearchAndMarkets.com
businesswire.com
GSK
JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth
prnewswire.com
MRK
GSK
House Dust Mite Disease Market to Exhibit Substantial Growth at a CAGR of 3.5% During the Forecast Period (2025-2034) | DelveInsight USA - English USA - English
prnewswire.com
ALKS
STG
GSK
SNY
TEVA
AZN
INCY
REGN
PFE
BMY
LLY
AMGN
ABBV
GILD
BIIB
CSL
VRTX
BHC
NVS
MRK
LEO
ALLT
CNTB
INM
Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight
globenewswire.com
JNJ
BIIB
NVS
VTRS
RPRX
ABBV
AZN
MRK
RIGL
GSK
REGN
GILD
AMGN
LLY
BMY
XBI
IBB
Adimab Records Another Year of Double-Digit Clinical Program Growth
prnewswire.com
GSK
BIIB
NVS
BMY
REGN
VRTX
LLY
MRK
ALNY
IVVD
ALE
SCHR